205 related articles for article (PubMed ID: 35856438)
1. Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors.
Suzuki H; Ohishi T; Asano T; Tanaka T; Saito M; Mizuno T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856438
[TBL] [Abstract][Full Text] [Related]
2. Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Mouse-Dog Chimeric Anti-HER2 Monoclonal Antibody (H77Bf).
Suzuki H; Asano T; Ohishi T; Yoshikawa T; Suzuki H; Mizuno T; Tanaka T; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2023 Feb; 42(1):34-40. PubMed ID: 36383106
[TBL] [Abstract][Full Text] [Related]
3. Defucosylated Mouse-Dog Chimeric Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H77Bf) Exerts Antitumor Activities in Mouse Xenograft Models of Canine Osteosarcoma.
Nanamiya R; Ohishi T; Suzuki H; Mizuno T; Yoshikawa T; Asano T; Tanaka T; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2023 Feb; 42(1):27-33. PubMed ID: 36399552
[TBL] [Abstract][Full Text] [Related]
4. An Anti-HER2 Monoclonal Antibody H
Tateyama N; Asano T; Ohishi T; Takei J; Hosono H; Nanamiya R; Tanaka T; Sano M; Saito M; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):184-190. PubMed ID: 34424760
[TBL] [Abstract][Full Text] [Related]
5. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Exerted Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor.
Tanaka T; Ohishi T; Saito M; Suzuki H; Kaneko MK; Kawada M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):142-149. PubMed ID: 35666554
[TBL] [Abstract][Full Text] [Related]
6. Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor by Defucosylated Mouse-Dog Chimeric Anti-Epidermal Growth Factor Receptor Antibody (E134Bf).
Li G; Suzuki H; Takei J; Asano T; Sano M; Tanaka T; Harada H; Mizuno T; Ohishi T; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):53-58. PubMed ID: 35471048
[TBL] [Abstract][Full Text] [Related]
7. Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma.
Tateyama N; Suzuki H; Ohishi T; Asano T; Tanaka T; Mizuno T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432687
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models.
Li G; Suzuki H; Ohishi T; Asano T; Tanaka T; Yanaka M; Nakamura T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
Int J Mol Med; 2023 Feb; 51(2):. PubMed ID: 36660940
[TBL] [Abstract][Full Text] [Related]
9. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody (134-mG
Nanamiya R; Takei J; Ohishi T; Asano T; Tanaka T; Sano M; Nakamura T; Yanaka M; Handa S; Tateyama N; Harigae Y; Saito M; Suzuki H; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Feb; 41(1):1-7. PubMed ID: 35225663
[TBL] [Abstract][Full Text] [Related]
10. Defucosylated Mouse-Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors.
Li G; Ohishi T; Kaneko MK; Takei J; Mizuno T; Kawada M; Saito M; Suzuki H; Kato Y
Cells; 2021 Dec; 10(12):. PubMed ID: 34944112
[TBL] [Abstract][Full Text] [Related]
11. Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody.
Goto N; Suzuki H; Ohishi T; Harakawa A; Li G; Saito M; Takei J; Tanaka T; Asano T; Sano M; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):67-73. PubMed ID: 35377239
[TBL] [Abstract][Full Text] [Related]
12. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 134-mG
Tateyama N; Nanamiya R; Ohishi T; Takei J; Nakamura T; Yanaka M; Hosono H; Saito M; Asano T; Tanaka T; Sano M; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):177-183. PubMed ID: 34424762
[TBL] [Abstract][Full Text] [Related]
13. A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG
Kawabata H; Suzuki H; Ohishi T; Kawada M; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):59-66. PubMed ID: 35471051
[TBL] [Abstract][Full Text] [Related]
14. A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
Takei J; Kaneko MK; Ohishi T; Hosono H; Nakamura T; Yanaka M; Sano M; Asano T; Sayama Y; Kawada M; Harada H; Kato Y
Oncol Rep; 2020 Nov; 44(5):1949-1960. PubMed ID: 33000243
[TBL] [Abstract][Full Text] [Related]
15. Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
Asano T; Ohishi T; Takei J; Nakamura T; Nanamiya R; Hosono H; Tanaka T; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184091
[TBL] [Abstract][Full Text] [Related]
16. An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models.
Tanaka T; Ohishi T; Asano T; Takei J; Nanamiya R; Hosono H; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013368
[TBL] [Abstract][Full Text] [Related]
17. A Defucosylated Mouse Anti-CD10 Monoclonal Antibody (31-mG
Kawabata H; Ohishi T; Suzuki H; Asano T; Kawada M; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):320-327. PubMed ID: 35483055
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activities against breast cancers by an afucosylated anti-HER2 monoclonal antibody H
Tanaka T; Suzuki H; Ohishi T; Kaneko MK; Kato Y
Cancer Sci; 2024 Jan; 115(1):298-309. PubMed ID: 37942574
[TBL] [Abstract][Full Text] [Related]
19. Defucosylated Monoclonal Antibody (H
Suzuki H; Ohishi T; Nanamiya R; Kawada M; Kaneko MK; Kato Y
Curr Issues Mol Biol; 2023 Sep; 45(10):7734-7748. PubMed ID: 37886932
[TBL] [Abstract][Full Text] [Related]
20. Anti‑EGFR monoclonal antibody 134‑mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
Hosono H; Takei J; Ohishi T; Sano M; Asano T; Sayama Y; Nakamura T; Yanaka M; Kawada M; Harada H; Kaneko MK; Kato Y
Int J Mol Med; 2020 Oct; 46(4):1443-1452. PubMed ID: 32945346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
